1 Min Read
Nov 16 (Reuters) - Recce Ltd:
* U.S. Food And Drug Administration has granted qualified infectious disease product designation for its lead compound Recce® 327 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.